Chen, T. L., Harrington, B., Truxall, J., Wasmuth, R., Prouty, A., Sloan, S., . . . Hertlein, E. (2021). Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL. J Hematol Oncol.
Chicago Style CitationChen, Timothy L., et al. "Preclinical Evaluation of the Hsp90 Inhibitor SNX-5422 in Ibrutinib Resistant CLL." J Hematol Oncol 2021.
Cita MLAChen, Timothy L., et al. "Preclinical Evaluation of the Hsp90 Inhibitor SNX-5422 in Ibrutinib Resistant CLL." J Hematol Oncol 2021.
Atenció: Aquestes cites poden no estar 100% correctes.